Nodal Marginal Zone Lymphoma
Nodal Marginal Zone Lymphoma (NMZL) is an indolent B-cell lymphoma that is found mostly in the lymph nodes. The disease is rare and only accounts for 1% of all Non-Hodgkin’s Lymphomas (NHL). It is most commonly diagnosed in older patients, with women more susceptible than men.
The disease is classified as a marginal zone lymphoma because the mutation occurs in the marginal zone of the B-cells. Due to its confinement in the lymph nodes, this disease is also classified as nodal.
Diagnosis and Staging
Symtoms include:
- Painless swelling of the lymph nodes
- Fever
- Night sweats
- Fatigue
- Weight loss
Diagnosis is made using a lymph node biopsy. Other tests, such as X-rays, CT scan, PET scan, ultrasound, and bone marrow biopsy are used to stage the disease. Staging is as follows:
- Stage I
- Only one group of lymph nodes is involved,
- Stage II
- Two groups of lymph nodes are involved, but they are on the same side of the diaphragm.
- Stage III
- Lymph nodes on both sides of the diaphragm are involved. The spleen is considered a lymph node in this staging system, so its involvement marks stage III.
- Stage IV
- The bone marrow, liver, or other organs are involved.
Most patients are diagnosed in the earlier stages of disease.
Treatment
As this is a very slow growing disease, the "Watch and Wait" method may be employed for patients who don’t have many symptoms. Other treatment include:
- Chemotherapy
- NMZL is very reactive to chemotherapy. Administration of the drugs chlorambucil and/or fludarabine usually results in remission of the disease.
- Radiation
- Radiotherapy is given alone in the early stages of disease, or in combination with chemotherapy for late stages of the disease.
- Radiolabeled Isotopes
- Radioimmunotherapy treatments such as the Zevalin regimen are being researched as a treatment for marginal zone lymphomas and shows promising results.
- Clinical Trials
- Patients who are looking for more advanced treatment or who have lymphoma that does not respond to standard treatment may want to consider a clinical study. Click here to find clinical trials in your area.
Related Articles
More Articles
More Articles
This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...
In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...
BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...
There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...
The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...
Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...
MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...
Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...
After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...
According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...
In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...
Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...
Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...
In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...
Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...
